Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.

Saved in:
Bibliographic Details
Title: Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.
Authors: Pinzone MR; Department of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, Italy. cacopardobruno@inwind.it., Zanghì AM, Rapisarda L, D'Agata V, Benanti F, Spartà D, Nunnari G, Cacopardo B
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2014 Dec; Vol. 18 (2 Suppl), pp. 11-5.
Publication Type: Journal Article
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729